Eversept Partners, LP Dexcom Inc Transaction History

Eversept Partners, LP

$1.26 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Nov 08, 2023	SELL	$67.99 - $132.89 $947,508 - $1.85 Million	-13,936 Reduced 49.06%	14,468 $1.08 Million
Q2 2022 Aug 15, 2022	SELL	$67.99 - $132.89 $947,508 - $1.85 Million	-13,936 Reduced 49.06%	14,468 $1.08 Million
Q1 2022 Nov 08, 2023	BUY	$94.08 - $130.2 $2.67 Million - $3.7 Million	28,404 New	28,404 $3.63 Million
Q1 2022 May 16, 2022	BUY	$94.08 - $130.2 $2.07 Million - $2.86 Million	22,003 Added 343.74%	28,404 $14.5 Million
Q3 2021 Nov 08, 2023	SELL	$106.71 - $143.18 $333,362 - $447,294	-3,124 Reduced 32.8%	6,401 $875,000
Q3 2021 Nov 15, 2021	SELL	$106.71 - $143.18 $333,362 - $447,294	-3,124 Reduced 32.8%	6,401 $3.5 Million
Q2 2021 Nov 08, 2023	SELL	$80.99 - $107.93 $746,403 - $994,682	-9,216 Reduced 49.18%	9,525 $1.02 Million
Q2 2021 Aug 16, 2021	SELL	$80.99 - $107.93 $746,403 - $994,682	-9,216 Reduced 49.18%	9,525 $4.07 Million
Q1 2021 Nov 08, 2023	BUY	$84.79 - $104.74 $1.38 Million - $1.7 Million	16,268 Added 657.82%	18,741 $1.68 Million
Q1 2021 May 13, 2021	BUY	$84.79 - $104.74 $1.38 Million - $1.7 Million	16,268 Added 657.82%	18,741 $6.74 Million
Q4 2020 Nov 08, 2023	BUY	$78.0 - $104.5 $192,894 - $258,428	2,473 New	2,473 $228,000
Q4 2020 Feb 16, 2021	SELL	$78.0 - $104.5 $327,366 - $438,586	-4,197 Reduced 62.92%	2,473 $914,000
Q2 2020 Nov 08, 2023	SELL	$62.68 - $105.34 $806,503 - $1.36 Million	-12,867 Reduced 65.86%	6,670 $676,000
Q2 2020 Aug 13, 2020	SELL	$62.68 - $105.34 $806,503 - $1.36 Million	-12,867 Reduced 65.86%	6,670 $2.7 Million
Q1 2020 Nov 08, 2023	BUY	$47.79 - $75.63 $357,803 - $566,241	7,487 Added 62.13%	19,537 $1.32 Million
Q1 2020 May 13, 2020	BUY	$47.79 - $75.63 $357,803 - $566,241	7,487 Added 62.13%	19,537 $5.26 Million
Q4 2019 Nov 08, 2023	SELL	$36.62 - $57.29 $1.19 Million - $1.86 Million	-32,500 Reduced 72.95%	12,050 $659,000
Q4 2019 Feb 13, 2020	SELL	$36.62 - $57.29 $1.19 Million - $1.86 Million	-32,500 Reduced 72.95%	12,050 $2.64 Million
Q3 2019 Nov 08, 2023	BUY	$35.53 - $43.8 $1.58 Million - $1.95 Million	44,550 New	44,550 $1.66 Million
Q3 2019 Nov 13, 2019	BUY	$35.53 - $43.8 $1.58 Million - $1.95 Million	44,550 New	44,550 $6.65 Million

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Eversept Partners, LP with notifications on news.

Account